LIVZON PHARMACEUTICAL GROUP INCLIVZON PHARMACEUTICAL GROUP INCLIVZON PHARMACEUTICAL GROUP INC

LIVZON PHARMACEUTICAL GROUP INC

No trades
See on Supercharts

1513 fundamentals

LIVZON PHARMACEUTICAL GROUP INC financial statements, including revenue, expenses, profit, and loss

The total revenue of 1513 for the last quarter is 3.01 B HKD, and it's 7.14% lower compared to the previous quarter. The net income of Q3 24 is 545.99 M HKD.

Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: HKD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth